Dr. Jean Carruthers and Dr. Sara Sangha Celebrate 20 Years of FDA Approval

Impossibile aggiungere al carrello

Puoi avere soltanto 50 titoli nel carrello per il checkout.

Riprova più tardi

Rimozione dalla Lista desideri non riuscita.

Riprova più tardi

Non è stato possibile aggiungere il titolo alla Libreria

Per favore riprova

Non è stato possibile seguire il Podcast

Per favore riprova

Esecuzione del comando Non seguire più non riuscita

Dr. Jean Carruthers and Dr. Sara Sangha Celebrate 20 Years of FDA Approval

Ascolta gratuitamente

Vedi i dettagli del titolo

A proposito di questo titolo

BOTOX® Cosmetic is a prescription treatment. All patients must be assessed by a licensed specialist to determine if BOTOX® Cosmetic is right for them. Twenty years ago, BOTOX® Cosmetic was FDA approved for temporary improvement in the appearance of moderate to severe frown lines in adults, making it the first product of its kind to enter the market. 1,2 Looking back on the 20-year journey, the brand is celebrating all of the people, including employees, partners, providers, and loyal patients, who have made BOTOX® Cosmetic what it is today. Listen as Dr. Sara Sangha, Associate Vice President of Medical Affairs at Allergan Aesthetics, speaks with Dr. Jean Carruthers, Ophthalmologist and Cosmetic Surgeon, about the past, present, and future of BOTOX® Cosmetic, and their personal experiences with the brand. Please see BOTOX® Cosmetic full Prescribing Information, including Boxed Warning and Medication Guide. Please see Important Safety Information here. References: 1. Data on File. AbbVie. FDA Product Approval Information, 2019 2. BOTOX® Cosmetic Prescribing Information, July 2020.

Ancora nessuna recensione